Bayview Pharmacy is pleased to present a specially compounded oral suspension formulation of Phenobarbital 3.24 mg/ml and Belladonna Leaf Alkaloids 0.025 mg/ml. This unique formulation is designed to address a range of disease states, including seizures, spasms, and cramps. The synergistic effect of these two active ingredients allows for a more potent treatment than if either ingredient were used independently.

Phenobarbital, a barbiturate, functions as a sedative and anticonvulsant, making it an effective treatment for seizures. On the other hand, Belladonna Leaf Alkaloids are anticholinergic agents that can help alleviate spasms and cramps. The combination of these two ingredients in this formulation enhances the overall effectiveness of the treatment.

This formulation is provided in an oral suspension form, a liquid dosage form in which one or more ingredients are dispersed uniformly throughout a liquid medium. This ensures a homogeneous mixture for administration, making it easier to administer and more palatable for patients. It is crucial to note that this formulation should only be used under the direct supervision of a healthcare professional.

If you have any inquiries about this formulation or wish to understand more about how it can help treat your patients' disease states, please do not hesitate to contact us at Bayview Pharmacy. We are committed to assisting you in finding the most suitable treatment options for your patients.

This compounded formulation of Phenobarbital 3.24 mg/ml and Belladonna Leaf Alkaloids 0.025 mg/ml in an Oral Suspension is specifically designed for the treatment of seizures, spasms, and other conditions associated with the central nervous system. It is crucial to understand that this formulation is contraindicated in patients with known hypersensitivity to either Phenobarbital or Belladonna Leaf Alkaloids. Furthermore, it should not be administered to patients with severe liver or kidney disease due to the potential increase in the risk of adverse effects.

Patients are strongly advised to abstain from alcohol while on this medication as it may exacerbate the risk of adverse effects. Regular monitoring for signs of sedation, confusion, and other CNS-related adverse effects is necessary. If any of these effects are observed, the dose may need to be adjusted accordingly. Similarly, patients should be monitored for signs of anticholinergic effects, such as dry mouth, blurred vision, and constipation. If these effects occur, dose adjustment may be necessary.

Caution is advised when using this formulation in patients with a history of glaucoma, as it may increase the risk of intraocular pressure. Similarly, it should be used with caution in patients with a history of urinary retention, as it may exacerbate this condition. If you have any questions or concerns about this formulation or its use, please do not hesitate to reach out for further information.

Phenobarbital 3.24 mg/ml/Belladonna Leaf Alkaloids 0.025 mg/ml Oral Suspension is a compounded formulation that combines two potent medications, Phenobarbital and Belladonna Leaf Alkaloids, to treat a variety of conditions. Phenobarbital, an anticonvulsant, is primarily used to manage and reduce the frequency of seizures. On the other hand, Belladonna Leaf Alkaloids are anticholinergic agents that are effective in treating spasms in the gastrointestinal tract, urinary tract, and biliary tract.

This unique combination of medications is particularly beneficial in managing conditions such as irritable bowel syndrome, urinary incontinence, and biliary colic. When administered orally, both Phenobarbital and Belladonna Leaf Alkaloids are absorbed into the bloodstream and distributed throughout the body. The Phenobarbital component works by reducing the severity and frequency of seizures, while the Belladonna Leaf Alkaloids work by relaxing the muscles in the gastrointestinal, urinary, and biliary tracts. This dual action helps to alleviate spasms and improve symptoms associated with the aforementioned conditions.

It is crucial to adhere to the prescribed dosage when taking this medication. Overdosing or underdosing can lead to undesirable effects or reduced efficacy. To minimize the risk of stomach upset, it is recommended to take this medication with food or a full glass of water. Side effects such as nausea, vomiting, or dizziness should be reported to your doctor immediately.

If you have any queries about this compounded formulation or its mechanism of action, do not hesitate to ask. It is our responsibility to ensure you are well-informed about your treatment options and how they work.

This compounded formulation of Phenobarbital 3.24 mg/ml and Belladonna Leaf Alkaloids 0.025 mg/ml is presented in an oral suspension. This means that the active ingredients are uniformly dispersed throughout a liquid medium, ensuring a homogeneous mixture for administration. This formulation is versatile and may be used to treat a variety of conditions.

It can be used in the management of spasticity, tetanus, and alcohol withdrawal. It may also serve as a preoperative sedative, helping to alleviate anxiety and tension before surgery. Furthermore, it can be used to manage symptoms of Parkinson’s disease, such as tremors, rigidity, and difficulty with movement.

However, it is crucial to note that this formulation is contraindicated in patients with glaucoma, myasthenia gravis, or a history of depression. It is also important to be aware of potential side effects, which may include drowsiness, dizziness, and blurred vision.

As with any medication, it is essential to use this formulation under the guidance of a healthcare professional. If you have any questions or concerns about the use of this formulation, please consult with your healthcare provider.